Език: EN EN
← Назад към резултатите
Активно (без набиране) Не е приложимо NCT06880627

Brain Boost Program to Improve Cognitive Function in People With Systemic Sclerosis

Не е приложима фаза (напр. обсервационно)
Заболявания: Scleroderma

Спонсор: University of Michigan

Налично на: БГ
Обобщение
The purpose of this study is to examine whether an 8-week online educational group-based program tailored to people with systemic sclerosis can help improve cognitive function and well-being. The study team hypothesize that participants that receive the intervention will have better improvements immediately after treatment at week 8 in all cognitive function measures, non-cognitive symptoms, and self-management compared to those in the waitlist control.
Кой може да участва
Inclusion Criteria: * Have physician-diagnosis of Systemic sclerosis (SSc) (any subtype) * A score of ≥ 10 on the Perceived Deficits Questionnaire * A score of ≤ 7 on the 6-Item Cognitive Impairment Test * Have access to a reliable, internet-connected device (e.g. computer, smartphone, tablet) * Visual acuity with correction sufficient to work on a computer, smartphone, tablet or screen * Be able to read, speak, and understand English Exclusion Criteria: * Diagnosis of dementia or head injury * Other neurological disorders that might impact cognition * Have major psychiatric disorder such as major depression and schizophrenia * Complex, unstable health issues that would preclude full participation in the study (like a planned surgery or active cancer treatment)
Интервенции
Brain Boost group
BEHAVIORAL
Waitlist group
OTHER
Места на провеждане 1
САЩ (1)
University of Michigan
Ann Arbor , Michigan
Технически детайли
Статус
Активно (без набиране)
Фаза
Не е приложимо
Вид изследване
INTERVENTIONAL
Пол
Мъже и жени
Минимална възраст
18 Years
Максимална възраст
70 Years
Здрави доброволци
Не
Начална дата
16.04.2025
Крайна дата
01.12.2026
Регистрационен номер
NCT06880627
Източник
clinicaltrials.gov
Запитване за медицински туризъм

Информацията е извлечена автоматично от ClinicalTrials.gov. Консултирайте се с вашия лекар преди да предприемете действия.